View Archive »
About The Cover
The cover for issue 5 of Oncotarget features Figure 2, "Survival curves in the KRAS, EGFR, and niche mutations cohorts," by Aramini, et al.
Table of Contents
Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo
Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo |
|
https://doi.org/10.18632/oncotarget.27380
Stephanie L. Merrigan,
Bomina Park,
Zaheer Ali,
Lasse D. Jensen,
Timothy W. Corson,
and Breandán N. Kennedy
|
| 493-509 |
Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease
Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease |
|
https://doi.org/10.18632/oncotarget.27433
Manish Charan,
Piyush Dravid,
Maren Cam,
Bhuvana Setty,
Ryan D. Roberts,
Peter J. Houghton,
and Hakan Cam
|
| 510-522 |
Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response
Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response |
|
https://doi.org/10.18632/oncotarget.27458
James Jabalee,
Rebecca Towle,
James Lawson,
Christopher Dickman,
and Cathie Garnis
|
| 523-534 |
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib |
|
https://doi.org/10.18632/oncotarget.27462
Raquel Carvalho Montenegro,
Alison Howarth,
Alessandro Ceroni,
Vita Fedele,
Batoul Farran,
Felipe Pantoja Mesquita,
Martin Frejno,
Benedict-Tilman Berger,
Stephanie Heinzlmeir,
Heba Z. Sailem,
Roberta Tesch,
Daniel Ebner,
Stefan Knapp,
Rommel Burbano,
Bernhard Kuster,
and Susanne Müller
|
| 535-549 |
Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study
Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study |
|
https://doi.org/10.18632/oncotarget.27472
Beatrice Aramini,
Federico Banchelli,
Stefania Bettelli,
Samantha Manfredini,
Roberto D’Amico,
Valentina Masciale,
Massimo Pinelli,
Margherita Moretti,
Alessandro Stefani,
Federica Bertolini,
Massimo Dominici,
Uliano Morandi,
and Antonino Maiorana
|
| 550-559 |
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas
Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas |
|
https://doi.org/10.18632/oncotarget.27342
Salvatore Lopez,
Emanuele Perrone,
Stefania Bellone,
Elena Bonazzoli,
Burak Zeybek,
Chanhee Han,
Joan Tymon-Rosario,
Gary Altwerger,
Gulden Menderes,
Anna Bianchi,
Luca Zammataro,
Aranzazu Manzano,
Paola Manara,
Elena Ratner,
Dan-Arin Silasi,
Gloria S. Huang,
Masoud Azodi,
Peter E. Schwartz,
Francesco Raspagliesi,
Roberto Angioli,
Natalia Buza,
Pei Hui,
Heather M. Bond,
and Alessandro D. Santin
|
| 560-570 |
Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts |
|
https://doi.org/10.18632/oncotarget.27440
Leonid Visochek,
Dikla Atias,
Itay Spektor,
Asher Castiel,
Talia Golan,
and Malka Cohen-Armon
|
| 571-572 |
Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines
Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines |
|
https://doi.org/10.18632/oncotarget.27475
Elpetra Timmermans-Sprang,
Rob W.J. Collin,
Arjen Henkes,
Meike Philipsen,
and Jan A. Mol
|
| 573-573 |
